July 10 (Reuters) - The U.S. Food and Drug
Administration has granted full approval for Moderna's ( MRNA )
COVID-19 vaccine, Spikevax, in children aged 6 months through 11
years who are at an increased risk of the disease, the company
said on Thursday.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Arun
Koyyur)